Monday - September 16, 2024

Interstitial Cystitis Clinical Trials 2024 (Updated): FDA Approvals, Medication, Pipeline, Therapies, Mechanism of Action, ROA and Companies by DelveInsight

Interstitial Cystitis Clinical Trials Interstitial Cystitis companies are Seikagaku Corporation, UCB, Alivio Therapeutics, Merck, Teva Pharmaceutical, Integrative Therapeutics, Lipella Pharmaceuticals, Addex Therapeutics, Imbrium Therapeutics, Ironwood Pharmaceuticals, others. (Albany, USA) DelveInsight’s, “Interstitial Cystitis Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and … Continue reading

Interstitial Lung Disease Clinical Trials 2024: FDA Approvals, Medication, Pipeline Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight

Interstitial Lung Disease Clinical Trials Interstitial Lung Disease companies are AstraZeneca, CSL Behring, Syndax Pharmaceuticals, Taiho Pharmaceutical, GenKyoTex, Kadmon Pharmaceuticals, Novartis, Ark Biosciences, Roche, PureTech Health, Avalyn Pharma, Bristol-Myers Squibb, Insmed, Bayer, HEC Pharm, Prometheus Biosciences, Boehringer Ingelheim, Genentech, FibroGen, … Continue reading